Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.6901
+0.0051 (0.74%)
Aug 7, 2025, 12:47 PM - Market open
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $5.14 million as of August 7, 2025. Its market cap has decreased by -15.11% in one year.
Market Cap
5.14M
Enterprise Value
-242.43K
1-Year Change
-15.11%
Ranking
Category
Stock Price
$0.69
Market Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $5.14M, a decrease of -92.13%. That is a compound annual growth rate of -47.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 5.10M | 27.81% |
| Dec 31, 2024 | 3.99M | -48.26% |
| Dec 29, 2023 | 7.71M | -58.92% |
| Dec 30, 2022 | 18.77M | -51.55% |
| Dec 31, 2021 | 38.74M | -40.66% |
| Sep 15, 2021 | 65.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 687.62B |
| Johnson & Johnson | 411.20B |
| AbbVie | 350.75B |
| AstraZeneca | 231.42B |
| Novartis AG | 228.98B |
| UnitedHealth Group | 227.69B |
| Abbott Laboratories | 227.46B |
| Novo Nordisk | 210.71B |